Australia - English - Department of Health (Therapeutic Goods Administration)

pfizer australia pty ltd - quinapril hydrochloride -

Australia - English - Department of Health (Therapeutic Goods Administration)

pfizer australia pty ltd - quinapril hydrochloride -

Australia - English - Department of Health (Therapeutic Goods Administration)

pfizer australia pty ltd - quinapril hydrochloride -

New Zealand - English - Medsafe (Medicines Safety Authority)

teva pharma (new zealand) limited - quinapril hydrochloride 10.85mg equivalent to 10 mg quinapril;  ; quinapril hydrochloride 10.85mg equivalent to 10 mg quinapril - film coated tablet - 10 mg - active: quinapril hydrochloride 10.85mg equivalent to 10 mg quinapril   excipient: crospovidone heavy magnesium carbonate hyprolose isopropyl alcohol macrogol 6000 magnesium stearate methacrylic acid copolymer purified talc titanium dioxide active: quinapril hydrochloride 10.85mg equivalent to 10 mg quinapril excipient: crospovidone heavy magnesium carbonate hyprolose isopropyl alcohol macrogol 6000 magnesium stearate methacrylic acid copolymer purified talc titanium dioxide - quinapril is indicated for the treatment of essential hypertension. quinapril is effective as monotherapy or concomitantly with diuretics and beta-blockers in patients with hypertension. quinapril is effective in the treatment of congestive heart failure when given concomitantly with a diuretic and/or digoxin.

New Zealand - English - Medsafe (Medicines Safety Authority)

teva pharma (new zealand) limited - quinapril hydrochloride 21.7mg equivalent to 20 mg quinapril;  ; quinapril hydrochloride 21.7mg equivalent to 20 mg quinapril - film coated tablet - 20 mg - active: quinapril hydrochloride 21.7mg equivalent to 20 mg quinapril   excipient: crospovidone heavy magnesium carbonate hyprolose iron oxide yellow isopropyl alcohol macrogol 6000 magnesium stearate methacrylic acid copolymer purified talc titanium dioxide active: quinapril hydrochloride 21.7mg equivalent to 20 mg quinapril excipient: crospovidone heavy magnesium carbonate hyprolose iron oxide yellow isopropyl alcohol macrogol 6000 magnesium stearate methacrylic acid copolymer purified talc titanium dioxide - quinapril is indicated for the treatment of essential hypertension. quinapril is effective as monotherapy or concomitantly with diuretics and beta-blockers in patients with hypertension. quinapril is effective in the treatment of congestive heart failure when given concomitantly with a diuretic and/or digoxin.

New Zealand - English - Medsafe (Medicines Safety Authority)

teva pharma (new zealand) limited - quinapril hydrochloride 5.425mg equivalent to 5 mg quinapril;  ; quinapril hydrochloride 5.425mg equivalent to 5 mg quinapril - film coated tablet - 5 mg - active: quinapril hydrochloride 5.425mg equivalent to 5 mg quinapril   excipient: crospovidone heavy magnesium carbonate hyprolose iron oxide yellow isopropyl alcohol macrogol 6000 magnesium stearate methacrylic acid copolymer purified talc titanium dioxide active: quinapril hydrochloride 5.425mg equivalent to 5 mg quinapril excipient: crospovidone heavy magnesium carbonate hyprolose iron oxide yellow isopropyl alcohol macrogol 6000 magnesium stearate methacrylic acid copolymer purified talc titanium dioxide - quinapril is indicated for the treatment of essential hypertension. quinapril is effective as monotherapy or concomitantly with diuretics and beta-blockers in patients with hypertension. quinapril is effective in the treatment of congestive heart failure when given concomitantly with a diuretic and/or digoxin.

United States - English - NLM (National Library of Medicine)

a-s medication solutions - quinapril hydrochloride (unii: 33067b3n2m) (quinaprilat - unii:34ssx5lde5) - quinapril 10 mg - hypertension quinapril tablets, usp are indicated for the treatment of hypertension, to lower blood pressure. lowering blood pressure reduces the risk of fatal and nonfatal cardiovascular events, primarily strokes and myocardial infarctions. these benefits have been seen in controlled trials of antihypertensive drugs from a wide variety of pharmacologic classes including the class to which this drug principally belongs. there are no controlled trials demonstrating risk reduction with quinapril tablets, usp. control of high blood pressure should be part of comprehensive cardiovascular risk management, including, as appropriate, lipid control, diabetes management, antithrombotic therapy, smoking cessation, exercise, and limited sodium intake. many patients will require more than one drug to achieve blood pressure goals. for specific advice on goals and management, see published guidelines, such as those of the national high blood pressure education program's joint national committee on prevention, d

United States - English - NLM (National Library of Medicine)

a-s medication solutions - quinapril hydrochloride (unii: 33067b3n2m) (quinaprilat - unii:34ssx5lde5) - quinapril 10 mg - hypertension quinapril is indicated for the treatment of hypertension, to lower blood pressure. lowering blood pressure reduces the risk of fatal and nonfatal cardiovascular events, primarily strokes and myocardial infarctions. these benefits have been seen in controlled trials of antihypertensive drugs from a wide variety of pharmacologic classes including the class to which this drug principally belongs. there are no controlled trials demonstrating risk reduction with quinapril. control of high blood pressure should be part of comprehensive cardiovascular risk management, including, as appropriate, lipid control, diabetes management, antithrombotic therapy, smoking cessation, exercise, and limited sodium intake. many patients will require more than one drug to achieve blood pressure goals. for specific advice on goals and management, see published guidelines, such as those of the national high blood pressure education program’s joint national committee on prevention, detection, evaluation, and treatment of

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

teva uk ltd - quinapril hydrochloride - oral tablet - 5mg

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

teva uk ltd - quinapril hydrochloride - oral tablet - 10mg